Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 41

1.

Subclinical First Trimester Renal Abnormalities Are Associated With Preeclampsia in Normoalbuminuric Women With Type 1 Diabetes.

Kelly CB, Hookham MB, Yu JY, Jenkins AJ, Nankervis AJ, Hanssen KF, Garg SK, Scardo JA, Hammad SM, Menard MK, Aston CE, Lyons TJ.

Diabetes Care. 2018 Jan;41(1):120-127. doi: 10.2337/dc17-1635. Epub 2017 Nov 9.

PMID:
29122892
2.

Broad induction of immunoregulatory mechanisms after a short course of anti-IL-7Rα antibodies in NOD mice.

Vazquez-Mateo C, Collins J, Fleury M, Dooms H.

BMC Immunol. 2017 Mar 29;18(1):18. doi: 10.1186/s12865-017-0201-4.

3.

Kidney Injury Marker 1 and Neutrophil Gelatinase-Associated Lipocalin in Chronic Kidney Disease.

Castillo-Rodriguez E, Fernandez-Prado R, Martin-Cleary C, Pizarro-Sánchez MS, Sanchez-Niño MD, Sanz AB, Fernandez-Fernandez B, Ortiz A.

Nephron. 2017;136(4):263-267. doi: 10.1159/000447649. Epub 2016 Oct 22. Review.

4.

A Rare Association of Hepatitis A Virus Infection with Type-1 Diabetes.

Hasosah M, Bokhari A, Alsahafi A, Sukkar G, Alzaben A.

Clin Pract. 2016 Jul 4;6(2):844. doi: 10.4081/cp.2016.844. eCollection 2016 Apr 26.

5.

Urinary Vitamin D Binding Protein and KIM-1 Are Potent New Biomarkers of Major Adverse Renal Events in Patients Undergoing Coronary Angiography.

Chaykovska L, Heunisch F, von Einem G, Alter ML, Hocher CF, Tsuprykov O, Dschietzig T, Kretschmer A, Hocher B.

PLoS One. 2016 Jan 11;11(1):e0145723. doi: 10.1371/journal.pone.0145723. eCollection 2016.

6.

Increased plasma kidney injury molecule-1 suggests early progressive renal decline in non-proteinuric patients with type 1 diabetes.

Nowak N, Skupien J, Niewczas MA, Yamanouchi M, Major M, Croall S, Smiles A, Warram JH, Bonventre JV, Krolewski AS.

Kidney Int. 2016 Feb;89(2):459-67.

7.

Kidney injury molecule-1 and neutrophil gelatinase associated lipocalin in normoalbuminuric diabetic children.

Ucakturk A, Avci B, Genc G, Ozkaya O, Aydin M.

J Pediatr Endocrinol Metab. 2016 Feb;29(2):145-51. doi: 10.1515/jpem-2015-0138.

PMID:
26393328
8.

Kidney injury molecule-1 and the loss of kidney function in diabetic nephropathy: a likely causal link in patients with type 1 diabetes.

Panduru NM, Sandholm N, Forsblom C, Saraheimo M, Dahlström EH, Thorn LM, Gordin D, Tolonen N, Wadén J, Harjutsalo V, Bierhaus A, Humpert PM, Groop PH; FinnDiane Study Group.

Diabetes Care. 2015 Jun;38(6):1130-7. doi: 10.2337/dc14-2330. Epub 2015 Mar 17.

PMID:
25784666
9.

Clinical & immunological profile of newly diagnosed patients with youth onset diabetes mellitus.

Dhanwal DK, Agarwal S, Garg S, Agarwal P.

Indian J Med Res. 2014 Sep;140(3):356-60.

10.

Picornavirus infection leading to immunosuppression.

Cusick MF, Libbey JE, Fujinami RS.

Future Virol. 2014 May 1;9(5):475-482.

11.

Blood kidney injury molecule-1 is a biomarker of acute and chronic kidney injury and predicts progression to ESRD in type I diabetes.

Sabbisetti VS, Waikar SS, Antoine DJ, Smiles A, Wang C, Ravisankar A, Ito K, Sharma S, Ramadesikan S, Lee M, Briskin R, De Jager PL, Ngo TT, Radlinski M, Dear JW, Park KB, Betensky R, Krolewski AS, Bonventre JV.

J Am Soc Nephrol. 2014 Oct;25(10):2177-86. doi: 10.1681/ASN.2013070758. Epub 2014 Jun 5.

12.

Role of viruses and other microbes in the pathogenesis of type 1 diabetes.

Kondrashova A, Hyöty H.

Int Rev Immunol. 2014 Jul-Aug;33(4):284-95. doi: 10.3109/08830185.2014.889130. Epub 2014 Mar 10. Review.

PMID:
24611784
13.

Galectin-9 and T cell immunoglobulin mucin-3 pathway is a therapeutic target for type 1 diabetes.

Kanzaki M, Wada J, Sugiyama K, Nakatsuka A, Teshigawara S, Murakami K, Inoue K, Terami T, Katayama A, Eguchi J, Akiba H, Yagita H, Makino H.

Endocrinology. 2012 Feb;153(2):612-20. doi: 10.1210/en.2011-1579. Epub 2011 Dec 20.

PMID:
22186414
14.

Effect of rituximab on human in vivo antibody immune responses.

Pescovitz MD, Torgerson TR, Ochs HD, Ocheltree E, McGee P, Krause-Steinrauf H, Lachin JM, Canniff J, Greenbaum C, Herold KC, Skyler JS, Weinberg A; Type 1 Diabetes TrialNet Study Group.

J Allergy Clin Immunol. 2011 Dec;128(6):1295-1302.e5. doi: 10.1016/j.jaci.2011.08.008. Epub 2011 Sep 9.

15.

Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy.

Nielsen SE, Andersen S, Zdunek D, Hess G, Parving HH, Rossing P.

Kidney Int. 2011 May;79(10):1113-8. doi: 10.1038/ki.2010.554. Epub 2011 Jan 26.

16.

Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase.

Vaidya VS, Niewczas MA, Ficociello LH, Johnson AC, Collings FB, Warram JH, Krolewski AS, Bonventre JV.

Kidney Int. 2011 Feb;79(4):464-70. doi: 10.1038/ki.2010.404. Epub 2010 Oct 27.

17.

Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril.

Nielsen SE, Schjoedt KJ, Astrup AS, Tarnow L, Lajer M, Hansen PR, Parving HH, Rossing P.

Diabet Med. 2010 Oct;27(10):1144-50. doi: 10.1111/j.1464-5491.2010.03083.x.

PMID:
20854382
18.

Fulminant Type 1 diabetes mellitus associated with acute hepatitis A.

Hwang YC, Jeong IK, Chon S, Oh S, Ahn KJ, Chung HY, Woo JT, Kim SW, Kim JW, Kim YS.

Diabet Med. 2010 Mar;27(3):366-7. doi: 10.1111/j.1464-5491.2010.02930.x. No abstract available.

PMID:
20536504
19.

Co-occurrence of allergic sensitization and type 1 diabetes.

Seiskari T, Viskari H, Kondrashova A, Haapala AM, Ilonen J, Knip M, Hyöty H.

Ann Med. 2010 Jul;42(5):352-9. doi: 10.3109/07853890.2010.481678.

PMID:
20465355
20.

Urinary tubular biomarkers of kidney damage: potential value in clinical practice.

Waanders F, Navis G, van Goor H.

Am J Kidney Dis. 2010 May;55(5):813-6. doi: 10.1053/j.ajkd.2010.02.002. No abstract available.

PMID:
20438985

Supplemental Content

Loading ...
Support Center